A. Teíchmann

1.1k total citations
43 papers, 608 citations indexed

About

A. Teíchmann is a scholar working on Reproductive Medicine, Public Health, Environmental and Occupational Health and Obstetrics and Gynecology. According to data from OpenAlex, A. Teíchmann has authored 43 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Reproductive Medicine, 10 papers in Public Health, Environmental and Occupational Health and 8 papers in Obstetrics and Gynecology. Recurrent topics in A. Teíchmann's work include Reproductive System and Pregnancy (6 papers), Endometriosis Research and Treatment (6 papers) and Reproductive Health and Contraception (6 papers). A. Teíchmann is often cited by papers focused on Reproductive System and Pregnancy (6 papers), Endometriosis Research and Treatment (6 papers) and Reproductive Health and Contraception (6 papers). A. Teíchmann collaborates with scholars based in Germany, China and United States. A. Teíchmann's co-authors include Zhijia Xia, Hao Chi, R. Thomssen, W. Kühn, Heinrich G. Köchel, Qin Wang, Dorothee Franziska Strohmer, Kai Sievert, Masyar Monazahian and Christoph Thomssen and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, American Journal of Obstetrics and Gynecology and International Journal of Cancer.

In The Last Decade

A. Teíchmann

41 papers receiving 586 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Teíchmann Germany 14 144 131 109 108 103 43 608
Qingqing Cai China 18 174 1.2× 88 0.7× 140 1.3× 45 0.4× 46 0.4× 53 696
Jieqiang Lv China 15 228 1.6× 72 0.5× 184 1.7× 155 1.4× 83 0.8× 37 645
Yanshi Wang China 15 148 1.0× 257 2.0× 70 0.6× 73 0.7× 48 0.5× 28 700
Taryn Summerfield United States 13 110 0.8× 136 1.0× 97 0.9× 30 0.3× 130 1.3× 38 503
G. Daxenbichler Austria 12 231 1.6× 104 0.8× 49 0.4× 25 0.2× 63 0.6× 40 713
Margaret A. Mobberley United Kingdom 15 388 2.7× 122 0.9× 358 3.3× 252 2.3× 58 0.6× 23 883
Ping Tai China 9 333 2.3× 393 3.0× 169 1.6× 128 1.2× 54 0.5× 12 841
Zacharias Fasoulakis Greece 14 386 2.7× 83 0.6× 51 0.5× 59 0.5× 84 0.8× 73 824
Avraham Geier Israel 14 256 1.8× 104 0.8× 45 0.4× 75 0.7× 47 0.5× 49 530

Countries citing papers authored by A. Teíchmann

Since Specialization
Citations

This map shows the geographic impact of A. Teíchmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Teíchmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Teíchmann more than expected).

Fields of papers citing papers by A. Teíchmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Teíchmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Teíchmann. The network helps show where A. Teíchmann may publish in the future.

Co-authorship network of co-authors of A. Teíchmann

This figure shows the co-authorship network connecting the top 25 collaborators of A. Teíchmann. A scholar is included among the top collaborators of A. Teíchmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Teíchmann. A. Teíchmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Tao, Yuan Chen, Xia Gu, et al.. (2023). Review of the Potential Therapeutic Effects and Molecular Mechanisms of Resveratrol on Endometriosis. International Journal of Women s Health. Volume 15. 741–763. 6 indexed citations
2.
Chi, Hao, et al.. (2023). Exosomes: A potential tool for immunotherapy of ovarian cancer. Frontiers in Immunology. 13. 1089410–1089410. 59 indexed citations
3.
Han, Li, et al.. (2023). Dermal repeated dose toxicity study of the anti-breast cancer drug Formestane cream in Bama minipig. Food and Chemical Toxicology. 178. 113927–113927. 1 indexed citations
4.
Gu, Xia, Jinrui Zhang, Yuan Chen, et al.. (2023). Beneficial biological effects of Flavokawain A, a chalcone constituent from kava, on surgically induced endometriosis rat model. Journal of Ethnopharmacology. 318(Pt A). 116896–116896. 3 indexed citations
5.
Yuan, Yuan, He Xian, Ping Liu, et al.. (2022). The effectiveness of single ultrasound-guided high-intensity focused ultrasound (USgHIFU) ablation in managing placenta accreta spectrum (PAS) disorder. Archives of Gynecology and Obstetrics. 307(4). 1037–1045. 2 indexed citations
6.
Chen, Jing, et al.. (2021). Utilizing the Hippo pathway as a therapeutic target for combating endocrine-resistant breast cancer. Cancer Cell International. 21(1). 306–306. 8 indexed citations
7.
Wang, Qin, et al.. (2021). Proteome Analysis of USP7 Substrates Revealed Its Role in Melanoma Through PI3K/Akt/FOXO and AMPK Pathways. Frontiers in Oncology. 11. 650165–650165. 17 indexed citations
8.
Yuan, Yuan, et al.. (2020). Focused Ultrasound Ablation Surgery combined with ultrasound-guided suction curettage in the treatment and management of Cesarean Scar Pregnancy. European Journal of Obstetrics & Gynecology and Reproductive Biology. 258. 168–173. 8 indexed citations
9.
Bothou, Αnastasia, et al.. (2019). Primary ovarian carcinoid tumors: our experience and review of the literature. European Journal of Gynaecological Oncology. 40(3). 361–367. 1 indexed citations
10.
Deng, Heng, Xiaofang Li, Jiamin Li, et al.. (2019). The beneficial androgenic action of steroidal aromatase inactivators in estrogen-dependent breast cancer after failure of nonsteroidal drugs. Cell Death and Disease. 10(7). 494–494. 5 indexed citations
11.
Tsikouras, Panagiotis, et al.. (2013). The contribution of catumaxomab in the treatment of malignant ascites in patients with ovarian cancer: a review of the literature. Archives of Gynecology and Obstetrics. 288(3). 581–585. 22 indexed citations
12.
Teíchmann, A., et al.. (2010). Gewalt gegen Frauen in der Schwangerschaft. Der Gynäkologe. 43(10). 853–859.
13.
Teíchmann, A., Dan Apter, Janusz Emerich, et al.. (2009). Continuous, daily levonorgestrel/ethinyl estradiol vs. 21-day, cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open-label trial. Contraception. 80(6). 504–511. 36 indexed citations
14.
Teíchmann, A., et al.. (2006). Comparative Trial of Continuous-Use and 21-Day Cyclic Levonorgestrel and Ethinyl Estradiol Oral Contraceptive. Obstetrics and Gynecology. 107(Supplement). 12S–12S. 13 indexed citations
15.
Sillem, Martin & A. Teíchmann. (2003). Patientinnenzentrierte Aspekte der Endometriose. Der Gynäkologe. 36(1). 41–52. 2 indexed citations
16.
Seeger, Harald, et al.. (2002). Effect of two oral contraceptives containing ethinylestradiol and levonorgestrel on serum and urinary surrogate markers of endothelial function. International Journal of Clinical Pharmacology and Therapeutics. 40(4). 150–157. 9 indexed citations
17.
Teíchmann, A., et al.. (1990). Premature rupture of the membranes and amniotic infections — the significance of laboratory tests. European Journal of Obstetrics & Gynecology and Reproductive Biology. 34(3). 217–222. 7 indexed citations
18.
Meden, H., W Rath, A. Teíchmann, & W. Kühn. (1989). Serumspiegel des Tumormarkers CA 125 vor der Second-look-Laparotomie beim primären epithelialen Ovarialkarzinom in Relation zu intraoperativen Befunden. Oncology Research and Treatment. 12(5). 217–220. 1 indexed citations
19.
Bartsch, H.H., et al.. (1988). Treatment of promyelocytic leukemia during pregnancy. Annals of Hematology. 57(1). 51–54. 10 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qingqing Cai Breakdown of academic impact, for papers by Jieqiang Lv Breakdown of academic impact, for papers by Yanshi Wang Breakdown of academic impact, for papers by Taryn Summerfield Breakdown of academic impact, for papers by G. Daxenbichler Breakdown of academic impact, for papers by Margaret A. Mobberley Breakdown of academic impact, for papers by Ping Tai Breakdown of academic impact, for papers by Zacharias Fasoulakis Breakdown of academic impact, for papers by Avraham Geier
Rankless by CCL
2026